Accordingly, we speculate that differential expression of Rb family members and/or posttranslational modifications of Rb that regulate interactions with E2F family members may contribute to the disparate regulation of BRCA1 in ovarian versus breast cancer. The gene discussed is BRCA1; the disease is breast carcinoma.